Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DuraDerm Medical is a healthcare company specializing in advanced wound care solutions through its proprietary micro-barrier film technology. The company's flagship product, DuraDerm, is an FDA-cleared liquid film that forms a sterile, breathable, and waterproof barrier over wounds and surgical sites. This technology is designed to prevent surgical site infections (SSIs) and promote healing by providing an antimicrobial environment without the use of antibiotics. DuraDerm is utilized across various clinical settings, including hospitals, wound care centers, and sports medicine, to manage acute and chronic wounds. The product's ability to conform to skin and maintain a barrier for up to 72 hours makes it a versatile tool for clinicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuraDerm Medical.